List of Tables
    Table 1. High Blood Pressure Drugs (Hypertension) CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. High Blood Pressure Drugs (Hypertension) Market Trends
    Table 3. High Blood Pressure Drugs (Hypertension) Market Drivers
    Table 4. High Blood Pressure Drugs (Hypertension) Market Challenges
    Table 5. High Blood Pressure Drugs (Hypertension) Market Restraints
    Table 6. Global High Blood Pressure Drugs (Hypertension) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States High Blood Pressure Drugs (Hypertension) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global High Blood Pressure Drugs (Hypertension) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States High Blood Pressure Drugs (Hypertension) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top High Blood Pressure Drugs (Hypertension) Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global High Blood Pressure Drugs (Hypertension) Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global High Blood Pressure Drugs (Hypertension) Revenue Share by Manufacturer, 2017-2022
    Table 13. Global High Blood Pressure Drugs (Hypertension) Sales by Manufacturer, (K MT), 2017-2022
    Table 14. Global High Blood Pressure Drugs (Hypertension) Sales Share by Manufacturer, 2017-2022
    Table 15. Global High Blood Pressure Drugs (Hypertension) Price by Manufacturer (2017-2022) & (USD/MT)
    Table 16. Global High Blood Pressure Drugs (Hypertension) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global High Blood Pressure Drugs (Hypertension) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in High Blood Pressure Drugs (Hypertension) as of 2021)
    Table 18. Top Players of High Blood Pressure Drugs (Hypertension) in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers High Blood Pressure Drugs (Hypertension) Product Type
    Table 20. Date of International Manufacturers Enter into High Blood Pressure Drugs (Hypertension) Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top High Blood Pressure Drugs (Hypertension) Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States High Blood Pressure Drugs (Hypertension) Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States High Blood Pressure Drugs (Hypertension) Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States High Blood Pressure Drugs (Hypertension) Sales by Players, (K MT), 2020, 2021 & 2022
    Table 26. United States High Blood Pressure Drugs (Hypertension) Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global High Blood Pressure Drugs (Hypertension) Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global High Blood Pressure Drugs (Hypertension) Sales in Volume by Region (2017-2022) & (K MT)
    Table 29. Global High Blood Pressure Drugs (Hypertension) Sales in Volume Forecast by Region (2023-2028) & (K MT)
    Table 30. Global High Blood Pressure Drugs (Hypertension) Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global High Blood Pressure Drugs (Hypertension) Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America High Blood Pressure Drugs (Hypertension) Sales in Volume by Country (2017-2028) & (K MT)
    Table 33. North America High Blood Pressure Drugs (Hypertension) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific High Blood Pressure Drugs (Hypertension) Sales in Volume by Region (2017-2028) & (K MT)
    Table 35. Asia Pacific High Blood Pressure Drugs (Hypertension) Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe High Blood Pressure Drugs (Hypertension) Sales in Volume by Country (2017-2028) & (K MT)
    Table 37. Europe High Blood Pressure Drugs (Hypertension) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America High Blood Pressure Drugs (Hypertension) Sales in Volume by Country (2017-2028) & (K MT)
    Table 39. Latin Americaa High Blood Pressure Drugs (Hypertension) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa High Blood Pressure Drugs (Hypertension) Sales in Volume by Country (2017-2028) & (K MT)
    Table 41. Middle East and Africa High Blood Pressure Drugs (Hypertension) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Eli Lilly Corporation Information
    Table 43. Eli Lilly Description and Business Overview
    Table 44. Eli Lilly High Blood Pressure Drugs (Hypertension) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 45. Eli Lilly High Blood Pressure Drugs (Hypertension) Product
    Table 46. Eli Lilly Recent Development
    Table 47. Pfizer Corporation Information
    Table 48. Pfizer Description and Business Overview
    Table 49. Pfizer High Blood Pressure Drugs (Hypertension) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 50. Pfizer Product
    Table 51. Pfizer Recent Development
    Table 52. Bayer Corporation Information
    Table 53. Bayer Description and Business Overview
    Table 54. Bayer High Blood Pressure Drugs (Hypertension) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 55. Bayer Product
    Table 56. Bayer Recent Development
    Table 57. Symplmed Corporation Information
    Table 58. Symplmed Description and Business Overview
    Table 59. Symplmed High Blood Pressure Drugs (Hypertension) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 60. Symplmed Product
    Table 61. Symplmed Recent Development
    Table 62. Novartis Corporation Information
    Table 63. Novartis Description and Business Overview
    Table 64. Novartis High Blood Pressure Drugs (Hypertension) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 65. Novartis Product
    Table 66. Novartis Recent Development
    Table 67. Merck Corporation Information
    Table 68. Merck Description and Business Overview
    Table 69. Merck High Blood Pressure Drugs (Hypertension) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 70. Merck Product
    Table 71. Merck Recent Development
    Table 72. Sanofi Corporation Information
    Table 73. Sanofi Description and Business Overview
    Table 74. Sanofi High Blood Pressure Drugs (Hypertension) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 75. Sanofi Product
    Table 76. Sanofi Recent Development
    Table 77. Boryung Corporation Information
    Table 78. Boryung Description and Business Overview
    Table 79. Boryung High Blood Pressure Drugs (Hypertension) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 80. Boryung Product
    Table 81. Boryung Recent Development
    Table 82. Reata Pharmaceuticals Corporation Information
    Table 83. Reata Pharmaceuticals Description and Business Overview
    Table 84. Reata Pharmaceuticals High Blood Pressure Drugs (Hypertension) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 85. Reata Pharmaceuticals Product
    Table 86. Reata Pharmaceuticals Recent Development
    Table 87. Lung Biotechnology Corporation Information
    Table 88. Lung Biotechnology Description and Business Overview
    Table 89. Lung Biotechnology High Blood Pressure Drugs (Hypertension) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 90. Lung Biotechnology Product
    Table 91. Lung Biotechnology Recent Development
    Table 92. Yuhan Corporation Information
    Table 93. Yuhan Description and Business Overview
    Table 94. Yuhan High Blood Pressure Drugs (Hypertension) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 95. Yuhan Product
    Table 96. Yuhan Recent Development
    Table 97. Takeda Corporation Information
    Table 98. Takeda Description and Business Overview
    Table 99. Takeda High Blood Pressure Drugs (Hypertension) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 100. Takeda Product
    Table 101. Takeda Recent Development
    Table 102. Alvogen Corporation Information
    Table 103. Alvogen Description and Business Overview
    Table 104. Alvogen High Blood Pressure Drugs (Hypertension) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 105. Alvogen Product
    Table 106. Alvogen Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. High Blood Pressure Drugs (Hypertension) Customers List
    Table 110. High Blood Pressure Drugs (Hypertension) Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. High Blood Pressure Drugs (Hypertension) Product Picture
    Figure 2. Global High Blood Pressure Drugs (Hypertension) Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global High Blood Pressure Drugs (Hypertension) Market Size 2017-2028 (US$ Million)
    Figure 4. Global High Blood Pressure Drugs (Hypertension) Sales 2017-2028 (K MT)
    Figure 5. United States High Blood Pressure Drugs (Hypertension) Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States High Blood Pressure Drugs (Hypertension) Market Size 2017-2028 (US$ Million)
    Figure 7. United States High Blood Pressure Drugs (Hypertension) Sales 2017-2028 (K MT)
    Figure 8. United States High Blood Pressure Drugs (Hypertension) Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States High Blood Pressure Drugs (Hypertension) Market Share in Global, in Volume (K MT) 2017-2028
    Figure 10. High Blood Pressure Drugs (Hypertension) Report Years Considered
    Figure 11. Product Picture of ACEI
    Figure 12. Product Picture of CCB
    Figure 13. Product Picture of ARB
    Figure 14. Global High Blood Pressure Drugs (Hypertension) Market Share by Type in 2022 & 2028
    Figure 15. Global High Blood Pressure Drugs (Hypertension) Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global High Blood Pressure Drugs (Hypertension) Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global High Blood Pressure Drugs (Hypertension) Sales by Type (2017-2028) & (K MT)
    Figure 18. Global High Blood Pressure Drugs (Hypertension) Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global High Blood Pressure Drugs (Hypertension) Price by Type (2017-2028) & (USD/MT)
    Figure 20. United States High Blood Pressure Drugs (Hypertension) Market Share by Type in 2022 & 2028
    Figure 21. United States High Blood Pressure Drugs (Hypertension) Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States High Blood Pressure Drugs (Hypertension) Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States High Blood Pressure Drugs (Hypertension) Sales by Type (2017-2028) & (K MT)
    Figure 24. United States High Blood Pressure Drugs (Hypertension) Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States High Blood Pressure Drugs (Hypertension) Price by Type (2017-2028) & (USD/MT)
    Figure 26. Product Picture of Hospital Pharmacy
    Figure 27. Product Picture of Retail Pharmacy
    Figure 28. Product Picture of Online Pharmacy
    Figure 29. Global High Blood Pressure Drugs (Hypertension) Market Share by Application in 2022 & 2028
    Figure 30. Global High Blood Pressure Drugs (Hypertension) Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global High Blood Pressure Drugs (Hypertension) Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global High Blood Pressure Drugs (Hypertension) Sales by Application (2017-2028) & (K MT)
    Figure 33. Global High Blood Pressure Drugs (Hypertension) Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global High Blood Pressure Drugs (Hypertension) Price by Application (2017-2028) & (USD/MT)
    Figure 35. United States High Blood Pressure Drugs (Hypertension) Market Share by Application in 2022 & 2028
    Figure 36. United States High Blood Pressure Drugs (Hypertension) Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States High Blood Pressure Drugs (Hypertension) Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States High Blood Pressure Drugs (Hypertension) Sales by Application (2017-2028) & (K MT)
    Figure 39. United States High Blood Pressure Drugs (Hypertension) Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States High Blood Pressure Drugs (Hypertension) Price by Application (2017-2028) & (USD/MT)
    Figure 41. North America High Blood Pressure Drugs (Hypertension) Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 42. North America High Blood Pressure Drugs (Hypertension) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. High Blood Pressure Drugs (Hypertension) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada High Blood Pressure Drugs (Hypertension) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe High Blood Pressure Drugs (Hypertension) Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 46. Europe High Blood Pressure Drugs (Hypertension) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany High Blood Pressure Drugs (Hypertension) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France High Blood Pressure Drugs (Hypertension) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. High Blood Pressure Drugs (Hypertension) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy High Blood Pressure Drugs (Hypertension) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia High Blood Pressure Drugs (Hypertension) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific High Blood Pressure Drugs (Hypertension) Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 53. Asia-Pacific High Blood Pressure Drugs (Hypertension) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China High Blood Pressure Drugs (Hypertension) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan High Blood Pressure Drugs (Hypertension) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea High Blood Pressure Drugs (Hypertension) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India High Blood Pressure Drugs (Hypertension) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia High Blood Pressure Drugs (Hypertension) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Taiwan High Blood Pressure Drugs (Hypertension) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia High Blood Pressure Drugs (Hypertension) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand High Blood Pressure Drugs (Hypertension) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia High Blood Pressure Drugs (Hypertension) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Philippines High Blood Pressure Drugs (Hypertension) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America High Blood Pressure Drugs (Hypertension) Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 65. Latin America High Blood Pressure Drugs (Hypertension) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico High Blood Pressure Drugs (Hypertension) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil High Blood Pressure Drugs (Hypertension) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina High Blood Pressure Drugs (Hypertension) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa High Blood Pressure Drugs (Hypertension) Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 70. Middle East & Africa High Blood Pressure Drugs (Hypertension) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey High Blood Pressure Drugs (Hypertension) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia High Blood Pressure Drugs (Hypertension) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. U.A.E High Blood Pressure Drugs (Hypertension) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. High Blood Pressure Drugs (Hypertension) Value Chain
    Figure 75. High Blood Pressure Drugs (Hypertension) Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed